Therefore, treatment strategies such as initial therapy with AIs, which reduce early distant recurrence events, can be expected to improve long-term survival outcomes. Switching to an AI following ...

When it comes to addressing nail health issues, Kerassentials has garnered significant attention. With numerous Kerassentials ...

A new Moffitt Cancer Center study has identified a specific immune response that may prevent the spread of breast cancer ...

Neoantigen-targeting PCVs are highly immunogenic in high-risk clear cell RCC and can target key driver mutations and induce antitumor immunity.

Downgrade to “REDUCE.” We cut our estimates by 5-25% over the forecast period to factor in the headwinds in the legacy transfer case business and slowdown in the EV business. Further ...

Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today ...

Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) ...

If the tumor recurrence is diagnosed in an area that surgeons can safely operate on, a second surgery might reduce the tumor size. This approach can alleviate pressure ... Advanced techniques like ...

Boryung announced on the 18th the launch of 'Ravetricks Capsule', a combination of aspirin and rabeprazole. Ravetricks is a ...